Medicon Hellas S.A. (ATH:MEDIC)
Greece flag Greece · Delayed Price · Currency is EUR
2.760
-0.010 (-0.36%)
At close: Aug 7, 2026

Medicon Hellas Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
17.9517.9518.1218.1220.7721.51
Revenue Growth
-3.16%-0.94%0.03%-12.77%-3.41%40.87%
Gross Profit
13.1113.1112.8813.0215.4815.69
Operating Income
2.212.211.651.783.854.99
Net Income
1.731.731.371.322.533.04
Earnings Per Share
0.390.390.310.300.570.69
EPS Growth
-8.69%26.81%3.38%-47.83%-16.68%301.85%

Revenue by Segment

Fiscal YearTTMFY 2025
Period EndingDec '25 Dec '25
Medical Machinery Reaction Agents
15.4415.44
Cosmetics
0.290.29
Diagnostic Laboratories
2.452.45
Other Intercompany Sales
-0.23-0.23
Total
17.9517.95

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10.6810.688.518.4610.2110.36
Total Debt
9.249.249.4410.6511.0312.11
Net Cash (Debt)
1.441.44-0.93-2.19-0.82-1.75
Net Cash Growth
------
Net Cash Per Share
0.320.32-0.21-0.50-0.18-0.40

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4.414.4120.881.254.79
Capital Expenditures
-1.5-1.5-1.01-1.59-0.41-0.55
Free Cash Flow
2.912.911-0.720.844.24
Free Cash Flow Growth
676.55%192.35%---80.15%80.99%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.04%73.04%71.07%71.86%74.52%72.94%
Operating Margin
12.30%12.30%9.10%9.84%18.52%23.18%
Pretax Margin
11.54%11.54%7.81%8.27%17.60%22.22%
Profit Margin
9.65%9.65%7.54%7.29%12.20%14.14%
FCF Margin
16.21%16.21%5.49%-3.95%4.05%19.70%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.130-0.1300.0600.153
Dividend Per Share Growth
15.38%-116.67%-60.82%-
Dividend Yield
4.71%-6.71%2.05%4.91%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.046.456.9911.146.467.09
P/FCF Ratio
4.193.849.59-19.455.09
PS Ratio
0.680.620.530.810.791.00